AdvisorShares Psychedelics ETF Rating $11.68 -0.22 (-1.85%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock AdvisorShares Psychedelics ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PSIL Aggregate RatingModerate Buy 2.92Holdings in PSIL have an aggregate rating of Moderate Buy based on 98 analyst ratings issued in the past year covering 13 companies (68.3% of the portfolio).PSIL Aggregate Price Target$11.68High Prediction$11.68Average Prediction$11.68Low Prediction$11.68Holdings in PSIL have an aggregate price target of $11.68 and a range of $11.68 to $11.68 covering 13 companies (68.3% of the portfolio).PSIL Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy3 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by AdvisorShares Psychedelics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 13 PSIL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.00%MNMDMind Medicine (MindMed)$6.23-3.1%2.1665 of 5 stars3.23$25.11 303.1%13Positive News7.52%SAGESage Therapeutics$7.793.6156 of 5 stars2.00$8.81 13.1%19Upcoming EarningsAnalyst ForecastNews Coverage6.93%NRXPNRx Pharmaceuticals$2.071.7633 of 5 stars3.20$28.25 1,264.7%56.91%ALKSAlkermes$27.84+0.6%4.7869 of 5 stars2.67$38.50 38.3%12Upcoming EarningsNews CoveragePositive News6.65%STIMNeuronetics$4.48+5.7%1.1785 of 5 stars2.67$5.50 22.8%36.54%ATAIAtai Life Sciences$1.46-4.6%2.5375 of 5 stars3.00$10.50 619.2%35.39%CMPSCOMPASS Pathways$3.82-4.3%2.3026 of 5 stars3.00$20.20 428.8%6News CoveragePositive News4.80%VTGNVistagen Therapeutics$2.22-5.1%1.8699 of 5 stars4.001News CoveragePositive News4.52%NEUPNeuphoria Therapeutics Inc. - Common Stock$5.04-2.9%1.1629 of 5 stars3.00$21.00 316.7%1Positive NewsGap Up4.42%GHRSGH Research$9.53+0.3%2.9835 of 5 stars3.00$30.86 223.8%7Upcoming EarningsNews Coverage4.21%NBIXNeurocrine Biosciences$106.73+0.9%4.8202 of 5 stars2.86$161.14 51.0%22Upcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage1.37%ENVBEnveric Biosciences$1.38+3.4%1.9333 of 5 stars3.00$10.00 624.6%1Gap Up1.03%RLMDRelmada Therapeutics$0.65-12.5%3.5077 of 5 stars2.00$4.25 558.8%5High Trading Volume This page (NYSEARCA:PSIL) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AdvisorShares Psychedelics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PSIL Stock Free PSIL Stock Alerts